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Abstract
Background: Considering that recent studies have demonstrated endothelial dysfunction in subjects with
periodontitis and that there is no information about vascular function in coexistence of periodontitis and
atherosclerosis, we assessed the impact of oral inoculation with the periodontal pathogen Porphyromonas gingivalis
on vascular reactivity in healthy and hypercholesterolemic apolipoprotein E-deficient (ApoE) mice. In vitro
preparations of mesenteric arteriolar bed were used to determine the vascular responses to acetylcholine, sodium
nitroprusside and phenylephrine (PE).
Results: Alveolar bone resorption, an evidence of periodontitis, was assessed and confirmed in all infected mice.
Acetylcholine- and sodium nitroprusside-induced vasorelaxations were similar among all groups. Non-infected
ApoE mice were hyperreactive to PE when compared to non-infected healthy mice. P gingivalis infection
significantly enhanced the vasoconstriction to PE in both healthy and spontaneous atherosclerotic mice, when
compared to their respective controls.
Conclusions: This study demonstrates that oral P gingivalis affects the alpha-adrenoceptor-mediated vascular
responsiveness in both healthy and spontaneous atherosclerotic mice, reinforcing the association between
periodontitis and cardiovascular diseases.
Background
Periodontal disease is a chronic inflammatory disease
that affects the gum tissue and other structures support-
ing the teeth. It begins as gingivitis and, if left untreated,
can progress to periodontitis, where destruction of con-
nective tissue attachment and alveolar bone can lead to
tooth loss. Beyond its local effects, periodontal disease
may also interfere with other systems of the body, and
many epidemiological studies have associated periodon-
titis with atherosclerosis. However, a causal relation
between both diseases remains controversial [1].
Investigators have proposed that periodic transient
bacteremia, which leads to invasion of vascular cells and
increase of the levels of circulating cytokines, accelerates
the atherogenic process [2]. Also, it has been reported
that P gingivalis, the periodontopathogen associated
with the most common form of periodontal disease,
accelerates atheroma formation [3-5], increases systemic
inflammatory markers [4,6-8], invades endothelium and
vascular smooth muscle cells [9,10] and appears to alter
endothelial function [11-15].
Endothelial dysfunction appears to be an early event
in the development of atherosclerosis [16] and also pre-
dicts plaque instability [17]. Support for the clinical
importance of vascular reactivity and endothelial dys-
function is provided by several studies demonstrating
increased cardiovascular disease risk in patients with
vascular dysfunction in coronary and peripheral arteries
[17-22].
On the basis of these observations, we aim to investi-
gate whether oral P gingivalis infection alters the vascu-
lar responsiveness in spontaneous atherosclerosis in
apolipoprotein E-deficient (ApoE) mice compared with
C57BL/6 (C57) wild-type mice. * Correspondence: raquelbinda@yahoo.com.br
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Experimental groups
Experiments were conducted on adult (30-week-old)
male C57 and ApoE mice from the Laboratory of Trans-
genes and Cardiovascular Control of the Federal Univer-
sity of Espirito Santo. Animal care and treatment were
approved by the institutional Ethics Committee for Use
of Animals (CEUA-Emescam, Protocol # 020/2007) and
were conducted in conformity with institutional guide-
lines, in compliance with international laws and policies.
C57 mice were used as animals systemically healthy.
C57 and ApoE animals were randomly divided in con-
trol (Ct) or infected (Pg) groups: C57 Ct, C57 Pg, ApoE
Ct, ApoE Pg.
Preparation of bacterial culture and oral infection
P gingivalis strain ATCC 33277 was obtained from the
Collection of Microorganisms of Reference (INCQS, Fio-
cruz, Brazil) and cultured in blood-agar supplemented
with hemin/menadione, under an anaerobic condition
[23]. At age of 18 weeks randomly selected mice were
infected with P gingivalis as follows. 10
9 CFU of live
bacteria (optical density of ≈ 0.8 at 660 nm) in 100 μL
of PBS with 2% carboxymethylcellulose was adminis-
tered via oral topical application three times at 2-day
intervals. Control mice received carboxymethylcellulose
in PBS. Infected mice were kept in microisolated cages
(Beiramar, Brazil).
Cholesterol and systemic inflammation analysis
At 30 weeks of age, under anesthesia with thiopental (40
m g / k gi . p . ) ,m i c ew e r es u b j e c t e dt ot h ea x i l l a r yp l e x u s
isolation and samples of blood were obtained by punc-
tion [24]. For each mouse two blood samples were col-
lected. Serum was obtained to determine the levels of
plasma total cholesterol by chromogenic assays (Bioclin,
Brazil). Blood was used to perform leucogram (Beckman
Coulter MAXM HMX, USA). Systemic host inflamma-
tory response or systemic inflammation was assessed by
neutrophils/lymphocytes ratio [25].
“In Vitro” preparation of the mesenteric arteriolar bed
Isolated mesenteric arteriolar beds were obtained 12
weeks after Pg i n g i v a l i sinoculation of the animals and
after blood samples collection. Briefly, the superior
mesenteric artery was cannulated (PE 50, Becton Dickin-
son, Sparks, MD, USA), and the intestine was immedi-
ately severed from the body. The mesenteric vascular
bed was perfused at a constant flow of 2 mL/min with
oxygenated (mixture of 95% O2 and 5% CO2, 37°C) phy-
siological salt solution (130 NaCl, 4.7 KCl, 1.6
CaCl2◦2H2O, 1.8 KH2PO4, 4.7 MgSO, 1.17 H2O, 14.9
NaHCO3, 0.026 EDTA, and 11.1 glucose; mmol/L),
using a roller pump (Harvard Apparatus, USA). The
bowel was removed to prevent the return of the Krebs’
solution through the venous system. After passing
through the vascular bed, the perfusate was artificially
drained out from the preparation. After a 40-min stabili-
zation period, the experimental protocol was initiated.
Mean perfusion pressure (MPP) was measured; as a
result of maintenance of a constant flow, changes in the
MPP represented changes in vascular resistance. The
vasoconstrictor response was assessed by stimulation of
a-adrenoceptors evoked by phenylephrine (PE; 0.001-
300 μg; Sigma-Aldrich). To study endothelium-depen-
dent and endothelium-independent vasodilation,
responses to acetylcholine (ACh; 10
-10 to 10
-3 mol/L;
Sigma-Aldrich) and sodium nitroprusside (SNP; 10
-10 to
10
-3 mol/L; Sigma-Aldrich) respectively were determined
as percentages of reductions in the precontractions
induced by 10
-5 mol/L PE (concentration that induces
60% to 80% of the maximal effect).
Quantification of atherosclerotic lesion area
After bowel removal the heart was perfused through
right atrium with 50 mL of PBS (0.1 M; pH 7.4), follow-
ing by 50 mL of formaldehyde (4%). Aorta was removed
a n ds t o r e di nb u f f e r e df i x a t i v es o l u t i o n ,a n dc r y o s t a t
sections were prepared, as previously described [26].
Atherosclerotic lesion area was quantified using a
microscope (Olympus, Japan) interfaced with a videoca-
mera (Hitachi, Japan) and an image analysis system
(Image J, USA). Mean lesion area per mouse was calcu-
lated by an investigator blinded to the experimental pro-
tocol and was expressed as μm
2.
Quantification of alveolar bone loss
Alveolar bone between first and second molars of the
left mandible was assessed by a morphometric method.
Briefly, after 15 minutes in boiling water mandible was
mechanically defleshed, exposed overnight in 3% hydro-
gen peroxide and immersed in bleach for 1 minute. The
bone level, that is, the distance from the cementum-
enamel junction (CEJ) to the alveolar bone crest (ABC)
was measured under a dissecting microscope (× 40)
with a total of 2 measurements per mouse. The mea-
surements were repeated two times per site in random
and blinded protocols. Because a greater distance from
the CEJ-ABC indicates less alveolar bone, bone levels
w e r ec o n v e r t e dt or e l a t i v ea m o u n t so fb o n eb yt h ef o l -
lowing calculation: 1/distance from CEJ-ABC [23]. The
values were normalized by converting bone values of
each mouse to a percentage of the mean value for
respective control mice group.
Statistical Analysis
Vascular responses are given as percentage of dilation
relative to the PE-induced preconstriction level. Values
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curve, the maximum effect (Emax)a n dt h ed o s eo fa g o -
nist that produced one-half of Emax (ED50)w e r ee s t i -
mated using nonlinear regression analysis (GraphPad
Software Inc., San Diego, CA). The sensitivity of the
agonists is expressed as pED50. One- and two-way
ANOVA, followed by Bonferroni t test, or unpaired Stu-
dent’s t test when appropriated, were used for statistical
analyses. p < 0.05 was considered statistically significant.
Results
Alveolar bone loss produced by oral infection with P
gingivalis
To determine the degree of local periodontal destruc-
tion, we dissected the mandibles after euthanasia and
measured alveolar bone loss. As summarized in Figure
1, infected mice displayed significantly increased alveolar
bone loss compared with the respective control, indi-
cated by a decrease in relative amounts of bone in
infected mice (C57 Ct; 100 ± 2 versus C57 Pg; 48 ± 6%;
ApoE Ct: 103 ± 6 versus ApoE Pg: 63 ± 2%, respectively;
p < 0.05 for all comparisons).
Effects of the oral P gingivalis infection on serum
cholesterol levels and systemic inflammatory response
We investigated if the oral infection with Pg i n g i v a l i s
modulated established risk factors for atherogenesis in
this murine model. No differences in total plasma cho-
lesterol were observed between infected and control
g r o u p si nb o t hC 5 7( C t :7 8±6v e r s u sP g :8 5±3m g /
dL) and ApoE groups (Ct: 523 ± 64 versus Pg: 629 ± 41
mg/dL) groups (Table 1). When systemic inflammation
w a sa n a l y z e dw eo b s e r v e da ni n c r e a s e( ~3 - f o l d )i n
neutrophils/lymphocytes ratio from mice with athero-
sclerosis compared to C57 in both control (ApoE: 0.17
± 0.01 versus C57: 0.06 ± 0.01; p < 0.05) and infected
(ApoE: 0.17 ± 0.02 versus C57: 0.05 ± 0.001; p <0 . 0 5 )
animals (Figure 2). However, oral Pg i n g i v a l i sinocula-
tion did not change (p > 0.05) the systemic inflamma-
tory status in both healthy and atherosclerotic mice,
when compared to their controls (Figure 2). Body
weight was also monitored and was similar among all
groups (Table 1).
Effects of the oral P gingivalis infection on atherosclerotic
lesion area
To evaluate if the oral infection with P gingivalis
amends the progression of atherosclerotic lesions, mor-
phometric analyses were used and demonstrated that
there were no differences (p > 0.05) in mean athero-
s c l e r o t i cl e s i o na r e ai ni n f e c t e dm i c ec o m p a r e dw i t h
c o n t r o l si nb o t hC 5 7( P g :0 . 7 5±0 . 2v e r s u sC t :0 . 6 6±
0.2 μm
2 ×1 0
3)a n dA p o E( P g :5 7 . 5±4 . 3v e r s u sC t :
41.25 ± 0.9 μm
2 ×1 0
3) groups (Figure 3).
Figure 1 Alveolar bone loss produced by oral infection with P
gingivalis in C57 and ApoE mice. C57 represents animals
systemically healthy and ApoE represents animals with spontaneous
atherosclerosis. The relative amounts of bone are significantly less in
infected (Pg) than in control (Ct) mice. Values are means ± SEM. * p
< 0.05 vs Ct group.
Table 1 Effects of Oral Infection with P gingivalis on
Serum Cholesterol and Body Weight
Parameters C57 Ct (8) C57 Pg (8) ApoE Ct (7) ApoE Pg (6)
Body weight (g) 35 ± 0.6 33 ± 0.6 34 ± 0.8 33 ± 1.5
Serum cholesterol
(mg/dL)
78 ± 6 85 ± 3 523 ± 64
† 629 ± 41
§
Values are mean ± SEM.
† vs C57 CT;
§ vs C57 Pg; p < 0.05.
Figure 2 Oral P gingivalis infection and systemic inflammation.
Atherosclerotic mice have increased neutrophils/lymphocytes ratio
when compared to C57. Ct: control animals; Pg: infected animals. *p
< 0.05 vs. C57.
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arteriolar bed responsiveness
We examined the effects of P gingivalis oral infection on
mesenteric arteriolar bed responsiveness to phenylephr-
ine, acetylcholine and sodium nitroprusside. As sum-
marized in Figure 4 (panel A) the spontaneous
atherosclerotic mice were hyperreactive to phenylephr-
ine when compared to systemically healthy mice (ApoE
C t :9 8±5m m H gv e r s u sC 5 7C t :7 9±3m m H g ;p <
0.05). Periodontitis caused by P gingivalis oral inocula-
tion enhanced (p < 0.05) the maximal response to phe-
nylephrine in all groups when compared to the
respective control group in both C57 (Pg; 92 ± 6 versus
Ct: 79 ± 3 mmHg) and ApoE (Pg: 119 ± 7 versus Ct: 98
± 5 mmHg) groups (Figure 4B and 4D). Figure 4 (panel
D) shows the preservation of the vascular hyperreactivity
to phenylephrine of atherosclerotic mice (119 ± 7
mmHg) compared to healthy mice (92 ± 6 mmHg; p <
0.05) even after P gingivalis infection. Despite of changes
in vasoconstrictor responses, neither endothelium-
dependent nor endothelium-independent vasodilations
were changed by P gingivalis oral infection (values
shown in Table 2).
Discussion
T h ep r e s e n ts t u d yw a sd e s i g n e dt ot e s tw h e t h e ro r a l
challenge with an established periodontal pathogen
amends vascular responsiveness in a murine model of
spontaneous atherosclerosis. Surprisingly, our data show
that oral P gingivalis infection not only increases the
vascular contractile response to phenylephrine in ather-
osclerotic mice but also in systemically healthy mice.
The ApoE model of atherosclerosis used in this study is
well established [27,28]. In agreement with previous
studies we detected high levels of plasma cholesterol in
ApoE mice fed a standard chow diet [28-31]. We also
noted that the systemic inflammation observed in this
study is consistent with the fact that atherosclerosis is a
systemic inflammatory disease [32]. An important find-
ing of this study is that oral P gingivalis inoculation did
not change the systemic inflammatory status in athero-
sclerosis, a result consiste n tw i t ht h a td e s c r i b e db y
Figure 3 Oral P gingivalis infection and atherosclerotic lesion
areas. Atherosclerotic mice have increased lesion areas when
compared to C57. Oral infection does not alter the mean
atherosclerotic lesion areas. Ct: control animals; Pg: infected animals.
*p < 0.05 vs. C57.
Figure 4 Phenylephrine dose-response curves in mesenteric
arteries of C57 and ApoE mice, 12 weeks after P gingivalis oral
inoculation. A: Effect of atherosclerosis on vasoconstriction; B:
Effects of oral infection on vascular contractile response in
systemically healthy mice; C: Effects of oral infection on vascular
contractile response in mice with atherosclerosis; D: Difference on
vascular contractile response between animals systemically healthy
and with atherosclerosis. Ct: control animals; Pg: infected animals. *p
< 0.05.
Table 2 Effects of Oral Infection with P gingivalis on
Vascular Reactivity to PE, ACh and SNP
Parameters C57 Ct (8) C57 Pg (8) ApoE Ct (7) ApoE Pg (6)
PE
Emax
(mmHg)
79 ± 2.7 92 ± 5.5* 98 ± 5
† 119 ± 7 *
‡
pED50 2.5 ± 0.09 2.37 ± 0.06 2.40 ± 0.07 2.3 ± 0.05
ACh
Emax (% of
relaxation)
76 ± 2.3 74.5 ± 1.4 75.5 ± 2.9 75 ± 3
pED50 6.15 ± 0.17 6.25 ± 0.1 6.12 ± 0.27 6 ± 0.18
SNP
Emax (% of
relaxation)
92 ± 1.3 89 ± 0.8 91 ± 2.5 92 ± 2
pED50 6.6 ± 0.07 6.71 ± 0.04 6.90 ± 0.10 6.7 ± 0.08
Values are mean ± SEM.
*Pg versus Ct;
†versus C57 Ct,
‡ versus C57 Pg; p < 0.05.
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detected systemic inflammatory response induced by
oral P gingivalis infection, although some authors have
reported an increase in systemic inflammatory markers
such as C-reactive protein, interleukin 6 and neutrophils
in subjects with periodontitis [6-8]. Therefore, more stu-
dies are necessary to elucidate this controversial data.
One consideration and limitation is that in the present
study we investigated the effects of only one periodontal
pathogen, while human periodontitis encloses several
microorganisms.
The oral P gingivalis infection did not influence the
serum cholesterol levels. This result is in agreement
with those found in mice infected with Pg i n g i v a l i s[4]
and humans [11] with periodontitis. Although literature
reports an increase in the area of atherosclerotic lesion
caused by P gingivalis in animal models [4,5,33,34], in
this study we did not find changes in the atherosclerotic
lesion area. We attribute this difference to different
methodologies used in the studies. Li et al. [5] reported
increase in the area of injury only after 14 intravenously
weekly inoculations of P gingivalis (10
7 CFU) in athero-
sclerotic mice. Animals inoculated for 10 weeks did not
show any change in the area of plaque [5]. In our study
we performed only three inoculations, and to mimic
normal conditions for which periodontal pathogens
could reach the circulatory system, the inoculation of P
gingivalis was oral topical, and not intravenously as
described by those authors. Lalla et al. [4] also observed
increased aortic lesions in ApoE mice after 15 inocula-
tions (10
12 CFU) with P gingivalis. Again, the number of
inoculations in that study was high and was performed
by oral gavage and anal topical application; the latter
mode used to establish a cycle of oral reinfection,
because mice use to be coprophagic. In the present
study, however, the extent of the injury may not have
changed because we used smaller burden of pathogens
(10
9 CFU), the inoculations were less sparse and smaller
in number, and because we used only oral topical inocu-
lation, that is more compatible with periodontitis in
humans. Despite of a great difficulty in establishing a
model of periodontitis similar to periodontal disease in
humans, P gingivalis inoculation reproduces the period-
ontal tissue destruction found in humans, making this
model well accepted to study periodontitis.
Endothelial dysfunction has been considered one of
the early steps in atherosclerosis [32]. Although
endothelial dysfunction has been frequently considered
when an impaired endothelium-dependent vasodilation
is observed, the localized modulation of vascular
endothelium to a nonadaptive functional state can be
termed as endothelial dysfunction [35]. In ApoE mice,
endothelial dysfunction, taken as an impaired endothe-
lium-dependent dilation, is controversial. Endothelial
dysfunction can be detected or not in ApoE mice
depending on the type of diet, age, gender, and type of
vessel [36-45]. Recently it was shown in the mesenteric
vascular bed from male ApoE mice vascular dysfunction,
characterized by increased pressor responsiveness to
norepinephrine, despite of normal endothelium-depen-
dent and -independent relaxations [44]. Similarly, we
observed a hyperreactive response to phenylephrine in
atherosclerotic animals without changes in endothelium-
dependent and -independent vasodilations to acetylcho-
line and sodium nitroprusside, respectively. At present,
the mechanism by which hypercholesterolemia alters
vascular responsiveness in mesenteric arteriolar bed is
unknown and further studies will try to elucidate this
issue.
Interestingly, the hyperreactivity to the a-adrenocep-
tor agonist in ApoE mice infected with P gingivalis was
exacerbated when compared with noninfected ApoE
animals. In the systemically healthy mice, the response
to phenylephrine was also increased, but if we compare
its maximal responses, the hyperreactivity was more
pronounced in ApoE mice. The mechanism by which
oral Pg i n g i v a l i sinfection interferes with the reactivity
to phenylephrine is unknown. However, based on the
finding of an increased production of endothelin in cre-
vicular fluid in subjects with periodontitis [46] and that
the actions of endothelin include cell proliferation,
migration and contraction [47], we speculate that one
of the possible mechanisms by which periodontitis leads
to exacerbated pressor response to a-adrenoceptor ago-
nists could be the increase of systemic levels of
endothelin.
Conclusions
In conclusion, in the present study we demonstrate that
oral P gingivalis infection amplifies the vasoconstrictor
hyperreactivity to phenylephrine in mice with sponta-
neous atherosclerosis. Moreover, in healthy mice the
oral P gingivalis infection also produces increased vaso-
constrictor response to this a-adrenoceptor agonist.
This finding supports the hypothesis that oral infection
with P gingivalis is one of several risk factors of cardio-
vascular diseases.
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